Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CVS Health Corp (NYSE:CVS)

81.98
Delayed Data
As of Jan 13
 -0.62 / -0.75%
Today’s Change
69.30
Today|||52-Week Range
106.67
+3.89%
Year-to-Date
CVS Regular Dividend: CVS will begin trading ex-dividend on 01/20/17 with a $0.50 dividend payable to shareholders of record as of 01/24/17.
Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals
Jan 13 / Zacks.com - Paid Partner Content
CVS Debuts Cheap EpiPen Alternative
Jan 12 / Zacks.com - Paid Partner Content
Hate Checking Your Portfolio? Try These 3 Stocks
Jan 13 / MotleyFool.com - Paid Partner Content
CVS cuts cost for generic EpiPen competitor
Jan 12 / CNNMoney.com
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlig...
Jan 13 / Zacks.com - Paid Partner Content
CVS Is the Latest to Rock Mylan's EpiPen Empire
Jan 12 / TheStreet.com - Paid Partner Content
Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank
Jan 12 / Zacks.com - Paid Partner Content
Is 2017 the Year of the Retail Famine?
Jan 10 / Zacks.com - Paid Partner Content
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days
Jan 12 / TheStreet.com - Paid Partner Content
Bridges Investment Counsel Inc Buys Thermo Fisher Scientific Inc, iShares Russell 100...
Jan 10 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close82.60
Today’s open82.70
Day’s range81.75 - 82.91
Volume4,809,230
Average volume (3 months)7,704,936
Market cap$87.4B
Dividend yield2.44%
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+16.72%
Earnings growth (this year)+12.54%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+9.99%
P/E ratio17.6
Price/Sales0.72
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
WBAWalgreen-0.10-0.12%
ESRXExpress Scripts Hold...-0.06-0.08%
RADRite Aid Corp-0.04-0.46%
DPLODiplomat Pharmacy In...+0.47+3.46%
Data as of 4:14pm ET, 01/13/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.67
Annual revenue (last year)$153.3B
Annual profit (last year)$5.2B
Net profit margin3.39%

Profile

Sector
Retail Trade
Industry
Drugstore Chains
President, CEO &
Non-Independent Director
Larry J. Merlo
Chief Financial Officer &
Executive Vice President
David M. Denton
Corporate headquarters
Woonsocket, Rhode Island

Forecasts


Search for Jobs